Pharmaceutical REPAI Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 8, 2019)
Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act
This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.
What just happenedOct 9, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseOct 8, 2019
- Oct 9, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 8, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 8, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Oct 8, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 8, 2019IntroReferralIntro-H
Introduced in House
- Oct 8, 2019IntroReferral1000
Introduced in House